Ken Griffin Electromed, Inc. Call Options Transaction History

Citadel Advisors LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$13.94 - $18.5 $46,002 - $61,050	-3,300 Reduced 42.31%	4,500 $67,000
Q1 2024 May 15, 2024	BUY	$10.02 - $17.61 $78,156 - $137,358	7,800 New	7,800 $125,000
Q3 2023 Nov 14, 2023	SELL	$9.24 - $11.43 $8,316 - $10,287	-900 Reduced 60.0%	600 $6,000
Q2 2023 Aug 14, 2023	BUY	$10.15 - $12.45 $5,075 - $6,225	500 Added 50.0%	1,500 $16,000
Q1 2023 May 15, 2023	SELL	$10.03 - $13.6 $26,078 - $35,360	-2,600 Reduced 72.22%	1,000 $10,000
Q4 2022 Feb 14, 2023	BUY	$9.62 - $10.62 $34,632 - $38,232	3,600 New	3,600 $37,000

2.33M

4.5K

4.3K

Ticker ELMD
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 8,492,200
Market Cap $172M
Description
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consist...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.